According to related industries, Korea Lily's Lyumjev has passed the Drug Committee of medical institutions such as Samsung Seoul Hospital, Seoul National University Hospital, Seoul Asan Hospital, Gangnam Severance Hospital, and Seoul National University Bundang Hospital.

This drug was approved in Korea in December 2021, and insurance benefits were applied from September last year. Lyumjev, postprandial insulin, is an 'Insulin Lispro' formulation that shows a quick effect and helps lower blood sugar levels in type 1 and type 2 diabetics who have increased blood sugar after meals or who have difficulty maintaining the target blood sugar range. Domestic approval was made based on data from the PRONTO cli